Home/Filings/4/0001209191-21-005218
4//SEC Filing

Shultz Randall 4

Accession 0001209191-21-005218

CIK 0001469443other

Filed

Jan 24, 7:00 PM ET

Accepted

Jan 25, 6:47 PM ET

Size

7.2 KB

Accession

0001209191-21-005218

Insider Transaction Report

Form 4
Period: 2021-01-21
Shultz Randall
Chief Technology Officer
Transactions
  • Award

    Stock Option (right to buy)

    2021-01-21+55,000115,000 total
    Exercise: $3.05Exp: 2031-01-21Common Stock (55,000 underlying)
  • Purchase

    Common Stock

    2020-08-03$3.16/sh+700$2,21213,000 total
Footnotes (2)
  • [F1]Reflects the purchase of 700 shares of the Issuer's Common Stock on 8/3/20 at a per share purchase price of $3.16 pursuant to participation in the Issuer's 2015 Employee Stock Purchase Plan.
  • [F2]The options will vest monthly in equal installments over a period of four years from the date of the grant, 01/21/2021, subject to the Participant's continued service.

Issuer

Arcadia Biosciences, Inc.

CIK 0001469443

Entity typeother

Related Parties

1
  • filerCIK 0001808500

Filing Metadata

Form type
4
Filed
Jan 24, 7:00 PM ET
Accepted
Jan 25, 6:47 PM ET
Size
7.2 KB